Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles

by Richard M. Meade, David P. Fairlie, Jody M. Mason
Published 2019-07-01

Selective antagonism of cJun for cancer therapy

by Andrew Brennan, James T. Leech, Neil M. Kad, Jody M. Mason
Published 2020-09-01

Insights Into Peptide Inhibition of Alpha-Synuclein Aggregation

by James H. Torpey, Richard M. Meade, Ravina Mistry, Jody M. Mason, Jillian Madine
Published 2020-10-01

Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc

by Sarah K. Madden, Aline Dantas de Araujo, Mara Gerhardt, David P. Fairlie, Jody M. Mason
Published 2021-01-01

Truncated and helix-constrained peptides with high affinity and specificity for the cFos coiled-coil of AP-1.

by Tara Rao, Gloria Ruiz-Gómez, Timothy A Hill, Huy N Hoang, David P Fairlie, Jody M Mason
Published 2013-01-01

Oral (−)-Epicatechin Inhibits Progressive Tau Pathology in rTg4510 Mice Independent of Direct Actions at GSK3β

by Katriona L. Hole, Lydia E. Staniaszek, Gayathri Menon Balan, Jody M. Mason, Jon T. Brown, Robert J. Williams
Published 2021-06-01